⌘K

07:10:02·857d

SECFilingvia Quantisnow

SEC Form 8-K filed by Deciphera Pharmaceuticals Inc.

ByQuantisnow·Wall Street's wire, on your screen.

DCPH· Deciphera Pharmaceuticals Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

SEC Form 15-12G filed by Deciphera Pharmaceuticals Inc.
SEC Form EFFECT filed by Deciphera Pharmaceuticals Inc.
EVP & Chief Medical Officer Sherman Matthew L was granted 34,157 shares and returned 72,029 shares to the company, closing all direct ownership in the company (SEC Form 4)
Chief Financial Officer Kelly Thomas Patrick was granted 34,157 shares and returned 72,029 shares to the company, closing all direct ownership in the company (SEC Form 4)
SVP, Chief Development Officer Pitman Jama was granted 20,163 shares and returned 53,951 shares to the company, closing all direct ownership in the company (SEC Form 4)